Trials / Completed
CompletedNCT05375305
A Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery
A Phase II/Ⅲ, Randomized, Double-Blind, Dose-explored, Active-controlled Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 320 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the analgesic efficacy of IV SHR8554 compared with morphine and placebo in patients with acute postoperative pain following orthopedic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR8554 Injection | SHR8554 Injection; high dose |
| DRUG | SHR8554 Injection | SHR8554 Injection; low dose |
| DRUG | Saline Solution | Saline Solution |
| DRUG | Morphine | Morphine |
Timeline
- Start date
- 2022-05-11
- Primary completion
- 2023-10-19
- Completion
- 2023-10-19
- First posted
- 2022-05-16
- Last updated
- 2023-12-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05375305. Inclusion in this directory is not an endorsement.